Retatrutide Shows Superior Outcomes Over Ozempic in Weight Loss and Blood Sugar Control | Retatrutide News

Eli Lilly's retatrutide outperformed Ozempic in a trial focused on weight loss and blood sugar control. This positions retatrutide as a potentially more...
Clinical Trials · November 4, 2026